Delivery Order SPE2DB22D7058-SPE2DB25FSUT3

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,864.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,380.94, is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 4,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,493.64, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product. The contract has an ultimate completion date of October 22, 2024 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $20,157.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, to support military healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a ceiling value of $6,039.33 and an ultimate completion date of November 25, 2024. This award is a delivery order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,179.64, is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical products. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,196.16, is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for various therapeutic purposes. The contract has a firm fixed price and runs through November 18, 2024. The award is not associated with a set-aside designation, indicating open competition....
This federal contract award, valued at $24,234.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical supply. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,459.59, is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of February 21, 2024 and was awarded on February 20, 2024. This delivery order is part of a larger...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the procurement of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $5,010.99. It has an ultimate completion date of September 20, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
  • SPE2DB22D7058
    Indefinite Delivery Contract
  • SPE2DB22D7058-SPE2DB25FSUT3
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,740.21, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a period of performance through February 13, 2025 and is a Firm Fixed Price contract. The award was not designated with any set-aside requirements, indicating open competition.

Generated 5/21/25, 10:16 AM